Investopedia: Agilent Grinding Through Challenging Market Conditions

It may not look like it on the basis of the last few quarters, but Agilent (NYSE: A ) is getting better. Weakness in multiple test and mea...

Investopedia: Pricing Still A Long-Term Risk, But Illumina Continues To Build A Sequencing Fortress

Between the disruptions created by Thermo Fisher 's (NYSE: TMO ) acquisition of Life Technologies, Roche (Nasdaq: RHHBY ) all but raisi...

Seeking Alpha: Pacific Biosciences Will Go Checkers Or Wreckers

I live in NASCAR country and it's not that rare to hear the expression "going checkers or wreckers" - meaning throwing cautio...

Seeking Alpha: Can New Management Drive New Growth At Techne?

Techne ( TECH ) has always been a little different in the realm of publicly-traded life science companies. While the company's headqu...

Seeking Alpha: Illumina Flexes Its Muscles A Bit

The strong revenue growth and lucrative margins of Illumina's ( ILMN ) core sequencing business has attracted ample competition over th...

Investopedia: Thermo Steps Up And Seals A Deal For Life Technologies

After months of speculation, Thermo Fisher (NYSE: TMO ) has brought its rumored pursuit of diversified lab equipment and supply manufacture...